NASDAQ:BCRX - BioCryst Pharmaceuticals Price Target & Analyst Ratings

$3.54
-0.08 (-2.21 %)
(As of 06/27/2019 03:58 AM ET)
Today's Range
$3.50
Now: $3.54
$3.67
50-Day Range
$2.87
MA: $4.57
$8.06
52-Week Range
$2.80
Now: $3.54
$9.95
Volume1.01 million shs
Average Volume1.52 million shs
Market Capitalization$390.51 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14

Analyst Ratings

BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for BioCryst Pharmaceuticals in the last 12 months. Their average twelve-month price target is $9.6429, suggesting that the stock has a possible upside of 172.40%. The high price target for BCRX is $15.00 and the low price target for BCRX is $4.50. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.562.562.752.75
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.6429$9.6429$12.9167$12.9167
Price Target Upside: 172.40% upside172.40% upside39.34% upside39.34% upside

BioCryst Pharmaceuticals (NASDAQ:BCRX) Consensus Price Target History

Price Target History for BioCryst Pharmaceuticals (NASDAQ:BCRX)

BioCryst Pharmaceuticals (NASDAQ:BCRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$16.00 ➝ $4.50LowView Rating Details
5/23/2019JMP SecuritiesLower Price TargetOutperform$18.00 ➝ $10.00HighView Rating Details
5/22/2019Jefferies Financial GroupLower Price TargetBuy$13.00 ➝ $8.00HighView Rating Details
5/22/2019HC WainwrightReiterated RatingBuyMediumView Rating Details
4/22/2019Piper Jaffray CompaniesSet Price TargetBuy$15.00MediumView Rating Details
4/2/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $8.00HighView Rating Details
8/8/2018JPMorgan Chase & Co.Initiated CoverageOverweight$9.00MediumView Rating Details
7/17/2018Bank of AmericaUpgradeUnderperform ➝ NeutralMediumView Rating Details
6/28/2018Seaport Global SecuritiesReiterated RatingNeutralLowView Rating Details
8/8/2017Noble FinancialReiterated RatingBuyLowView Rating Details
(Data available from 6/27/2017 forward)
This page was last updated on 6/27/2019 by MarketBeat.com Staff

Featured Article: How is inflation measured?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel